| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 10/11/2001 | CA2368966A1 New derivatives and analogues of galanthamine |
| 10/10/2001 | EP1142868A1 Amide derivatives |
| 10/10/2001 | EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 10/10/2001 | EP1140887A1 Phase transfer catalyzed method for preparing oxybisphthalic compounds |
| 10/10/2001 | EP1140886A1 Method for the preparation of 5-cyanophthalide |
| 10/10/2001 | EP1140846A1 Aspartic protease inhibitors |
| 10/10/2001 | EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 10/10/2001 | EP1140823A1 Glucagon antagonists/inverse agonists |
| 10/10/2001 | EP1140819A1 Alfa-sulfenimino acid derivatives |
| 10/10/2001 | EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 10/10/2001 | EP1140810A1 Benzenic sulphonamide derivatives and their uses |
| 10/10/2001 | EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 10/10/2001 | EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 10/10/2001 | EP1140799A1 Novel propargylether derivatives |
| 10/10/2001 | EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 10/10/2001 | EP1140181A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 10/10/2001 | EP1140066A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use |
| 10/10/2001 | EP1140047A2 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs |
| 10/10/2001 | EP0923566A4 High molecular weight polymer-based prodrugs |
| 10/10/2001 | CN1317001A Continuous process for production of anhydrosugar alcohols |
| 10/10/2001 | CN1316425A Photochromic diarylheterocycloethylene compounds sensitive to blue light and its preparing process and usage |
| 10/10/2001 | CN1072665C Preparation of unsaturated cyclic ethers |
| 10/10/2001 | CN1072663C Novel benzoyl guanidine derivatives, process for their preparation and thier use in the preparation of medicines |
| 10/09/2001 | US6300371 For therapy of inflammatory diseases |
| 10/09/2001 | US6300368 Anilide derivatives and antiarrhythmic agents containing the same |
| 10/09/2001 | US6300330 Blood coagulation factor x inhibitors as anticoagulants |
| 10/04/2001 | WO2001073332A2 Pipe joint assembly and method for using same |
| 10/04/2001 | WO2001072742A1 Bisamidino compounds as nhe-3 inhibitors |
| 10/04/2001 | WO2001072733A1 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents |
| 10/04/2001 | WO2001072732A2 Oxidation of 5-(hydroxymethyl) furfural to 2,5-diformylfuran and subsequent decarbonylation to unsubstituted furan |
| 10/04/2001 | WO2001072731A2 Enantioselective process for preparing arylated lactones and derivatives |
| 10/04/2001 | WO2001072730A1 Selective preventives/remedies for progressive lesions after organ damage |
| 10/04/2001 | WO2001072728A2 Novel piperazine derivatives |
| 10/04/2001 | WO2001072698A1 Optically active cyanobutantriol derivatives and process for preparing same |
| 10/04/2001 | WO2001072688A2 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
| 10/04/2001 | WO2001072685A2 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | WO2001072681A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-HYDROXY-η-BUTYROLACTONE |
| 10/04/2001 | WO2001021577A3 Melanin concentrating hormone antagonist |
| 10/04/2001 | US20010027256 Method for the preparation of citalopram |
| 10/04/2001 | US20010027211 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents |
| 10/04/2001 | US20010027203 Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist |
| 10/04/2001 | US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma |
| 10/04/2001 | US20010026901 (Meth) acrylate derivative, polymer and photoresist composition having lactone structure, and method for forming pattern by using it |
| 10/04/2001 | EP1138713A2 Compounds and their manufacture and use |
| 10/04/2001 | EP1138681A1 A process for the preparation of acyl heteroaromatic compounds from heteroaromatic compounds by metal ion exchanged clays |
| 10/04/2001 | EP1138679A1 HYDRONAPHTHO 2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF |
| 10/04/2001 | EP1137738A1 Process for the recovery of low molecular weight phenols, furfural, furfuryl alcohol and/or cellulose or cellulose-rich residues |
| 10/04/2001 | EP1137647A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137645A2 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 10/04/2001 | EP1137644A1 Benzofuran derivatives, their preparation and use |
| 10/04/2001 | EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137632A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137631A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 10/04/2001 | EP1137596A1 Polymetal oxide containing silver oxide and vanadium oxide and the use thereof |
| 10/04/2001 | EP0828726B1 Tricyclic inhibitors of matrix metalloproteinases |
| 10/04/2001 | EP0757673B1 Heterocyclylbenzonitriles |
| 10/04/2001 | DE10015248A1 Bisamidino-Verbindungen als NHE-3 Inhibitoren Bisamidino compounds as NHE-3 inhibitors |
| 10/04/2001 | DE10014670A1 Extraction of the anthelmintic santonin from Artemisia plants, comprises extraction with a non-polar solvent, partitioning between hexane-ethyl acetate and aqueous polar phase and chromatographing on silica gel |
| 10/04/2001 | CA2404626A1 Novel piperazine derivatives |
| 10/04/2001 | CA2403814A1 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | CA2400165A1 Oxidation of 5-(hydroxymethyl) furfural to 2,5-diformylfuran and subsequent decarbonylation to unsubstituted furan |
| 10/03/2001 | CN1316013A Process for preparing optically pure (S)-3,4-dihydroxybutyric acid derivatives |
| 10/03/2001 | CN1316012A Process for preparing optically pure (S)-3-hydroxy-gamma-butyrolactone |
| 10/03/2001 | CN1316011A Continuous process for preparing optically pure (S)-3,4-dihydroxybutyric acid derivatives |
| 10/03/2001 | CN1316010A Continuous process for preparing optically pure (S)-3-hydroxy-gamma-butyrolactone |
| 10/03/2001 | CN1316008A Process for preparing alpha-(1,4) linked oligosaccharide |
| 10/03/2001 | CN1315859A Substances having antiobese and visceral fat-reducing functions and utilization thereof |
| 10/03/2001 | CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates |
| 10/03/2001 | CN1072217C Process for producing 2-substituted-3,4-condensed heterocyclic benzoic acid |
| 10/03/2001 | CN1072216C Method of producing 1,4-butanediol and tetrahydrofuran from furan |
| 10/02/2001 | US6297401 A 3-nitrosalicylamide derivative effective against plant pytopathogens |
| 10/02/2001 | US6297389 Process for the production of gamma-butyrolactone |
| 10/02/2001 | US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297274 Nonpeptide endothelin antagonists with increased water solubility |
| 10/02/2001 | US6297271 Controlling take-all disease in a plant |
| 10/02/2001 | US6297217 Boronic ester and acid compounds, synthesis and uses |
| 10/02/2001 | CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof |
| 10/02/2001 | CA2116800C Agent for preventing adhesion of thallium 201 to container |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 09/27/2001 | WO2001070675A2 Inhibitors of histone deacetylase |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070672A2 Compounds and methods to treat alzheimer's disease |
| 09/27/2001 | WO2001032654A3 Novel heterocyclic compounds and their use as medicines |
| 09/27/2001 | WO2001017972A3 Novel herbicides |
| 09/27/2001 | WO2001004115A3 Novel process for synthesis of heteroaryl-substituted urea compounds |
| 09/27/2001 | US20010025105 Anticancer agent; Alzheimer's therapy |
| 09/27/2001 | US20010024749 Surface modified carbonaceous materials |
| 09/27/2001 | CA2404002A1 Inhibitors of histone deacetylase |
| 09/27/2001 | CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha. |
| 09/27/2001 | CA2401749A1 Compounds and methods to treat alzheimer's disease |
| 09/27/2001 | CA2401728A1 Difluorobutyric acid metalloprotease inhibitors |
| 09/26/2001 | EP1136479A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 09/26/2001 | EP1136477A1 Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 09/26/2001 | EP1136078A2 Combination of angiotensin converting enzyme inhibitor and side- effect-reduced amount of aldosterone antagonist |
| 09/26/2001 | EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 09/26/2001 | EP1135119A1 Glucose and lipid lowering compounds |
| 09/26/2001 | EP0934252B1 Amide derivatives and their use as pesticides |
| 09/26/2001 | CN1314884A 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same |